Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

Pharmacists' and older adults' perspectives on the benefits and barriers of Home Medicines Reviews - a qualitative study.

Weir KR, Naganathan V, Bonner C, McCaffery K, Rigby D, McLachlan AJ, Jansen J.

J Health Serv Res Policy. 2019 Sep 10:1355819619858632. doi: 10.1177/1355819619858632. [Epub ahead of print] No abstract available.

PMID:
31505975
2.

Adverse drug reactions due to opioid analgesic use in New South Wales, Australia: a spatial-temporal analysis.

Du W, Chong S, McLachlan AJ, Luo L, Glasgow N, Gnjidic D.

BMC Pharmacol Toxicol. 2019 Sep 5;20(1):55. doi: 10.1186/s40360-019-0333-7.

3.

Paracetamol is ineffective for acute low back pain even for patients who comply with treatment: complier average causal effect analysis of a randomized controlled trial.

Schreijenberg M, Christine Lin CW, McLachlan AJ, Williams CM, Kamper SJ, Koes BW, Maher CG, Billot L.

Pain. 2019 Aug 23. doi: 10.1097/j.pain.0000000000001685. [Epub ahead of print]

PMID:
31453982
4.

Abdominal functional electrical stimulation to assist ventilator weaning in critical illness: a double-blinded, randomised, sham-controlled pilot study.

McCaughey EJ, Jonkman AH, Boswell-Ruys CL, McBain RA, Bye EA, Hudson AL, Collins DW, Heunks LMA, McLachlan AJ, Gandevia SC, Butler JE.

Crit Care. 2019 Jul 24;23(1):261. doi: 10.1186/s13054-019-2544-0.

5.

Efficacy and Safety of Low-dose Codeine-containing Combination Analgesics for Pain: Systematic Review and Meta-Analysis.

Abdel Shaheed C, Maher CG, McLachlan AJ.

Clin J Pain. 2019 Oct;35(10):836-843. doi: 10.1097/AJP.0000000000000746.

PMID:
31318725
6.

The Need to Strengthen the Role of the Pharmacist in Sri Lanka: Perspectives.

Sakeena MHF, Bennett AA, McLachlan AJ.

Pharmacy (Basel). 2019 Jun 5;7(2). pii: E54. doi: 10.3390/pharmacy7020054.

7.

Anticholinergic medicines use among older adults before and after initiating dementia medicines.

Narayan SW, Pearson SA, Litchfield M, Le Couteur DG, Buckley N, McLachlan AJ, Zoega H.

Br J Clin Pharmacol. 2019 Sep;85(9):1957-1963. doi: 10.1111/bcp.13976. Epub 2019 Jul 7.

8.

Improving adherence to urate-lowering therapy in people living with gout.

Coleshill MJ, Aung E, Nguyen AD, Stocker SL, Baysari MT, Kamel B, Schulz M, McLachlan AJ, Day RO.

Int J Rheum Dis. 2019 Apr;22(4):542-544. doi: 10.1111/1756-185X.13566. No abstract available.

PMID:
30985997
9.

A comparative study regarding antibiotic consumption and knowledge of antimicrobial resistance among pharmacy students in Australia and Sri Lanka.

Sakeena MHF, Bennett AA, Carter SJ, McLachlan AJ.

PLoS One. 2019 Mar 13;14(3):e0213520. doi: 10.1371/journal.pone.0213520. eCollection 2019.

10.

Transcutaneous electric nerve stimulation (TENS) for acute low back pain: systematic review.

Binny J, Joshua Wong NL, Garga S, Lin CC, Maher CG, McLachlan AJ, Traeger AC, Machado GC, Shaheed CA.

Scand J Pain. 2019 Apr 24;19(2):225-233. doi: 10.1515/sjpain-2018-0124. Review.

PMID:
30849052
11.

Low-Dose Amitriptyline for Chronic Low Back Pain.

Lin CC, McLachlan AJ, Maher CG.

JAMA Intern Med. 2019 Mar 1;179(3):450. doi: 10.1001/jamainternmed.2018.8140. No abstract available.

PMID:
30830187
12.

Paracetamol versus placebo for knee and hip osteoarthritis.

Leopoldino AO, Machado GC, Ferreira PH, Pinheiro MB, Day R, McLachlan AJ, Hunter DJ, Ferreira ML.

Cochrane Database Syst Rev. 2019 Feb 25;2:CD013273. doi: 10.1002/14651858.CD013273.

PMID:
30801133
13.

Patterns of high-risk prescribing and other factors in relation to receipt of a home medicines review: a prospective cohort investigation among adults aged 45 years and over in Australia.

Du W, Gnjidic D, Pearson SA, Hilmer SN, McLachlan AJ, Blyth F, Viney R, Joshy G, Day C, Banks E.

BMJ Open. 2019 Feb 15;9(2):e027305. doi: 10.1136/bmjopen-2018-027305.

14.

Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John's Wort.

Adiwidjaja J, Boddy AV, McLachlan AJ.

Clin Pharmacokinet. 2019 Jul;58(7):911-926. doi: 10.1007/s40262-019-00736-6.

PMID:
30675694
15.

Combination Drug Therapy for the Management of Low Back Pain and Sciatica: Systematic Review and Meta-Analysis.

Mathieson S, Kasch R, Maher CG, Pinto RZ, McLachlan AJ, Koes BW, Lin CC.

J Pain. 2019 Jan;20(1):1-15. doi: 10.1016/j.jpain.2018.06.005. Epub 2018 Jul 3. Review.

PMID:
30585164
16.

The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.

Todd A, Jansen J, Colvin J, McLachlan AJ.

BMC Geriatr. 2018 Nov 29;18(1):295. doi: 10.1186/s12877-018-0978-x.

17.

Editorial: Drug delivery in older people - unique challenges and important opportunities.

McLachlan AJ, Cogger VC.

Adv Drug Deliv Rev. 2018 Oct;135:1-2. doi: 10.1016/j.addr.2018.11.002. No abstract available.

PMID:
30466511
18.

Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review.

Sakeena MHF, Bennett AA, McLachlan AJ.

Int J Antimicrob Agents. 2018 Dec;52(6):771-782. doi: 10.1016/j.ijantimicag.2018.09.022. Epub 2018 Oct 9.

PMID:
30312654
19.

A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation Study.

Adiwidjaja J, Boddy AV, McLachlan AJ.

CPT Pharmacometrics Syst Pharmacol. 2018 Dec;7(12):798-808. doi: 10.1002/psp4.12355. Epub 2018 Oct 24.

20.

Evaluation of the impact of pharmacist-led medication reconciliation intervention: a single centre pre-post study from Ethiopia.

Mekonnen AB, McLachlan AJ, Brien JE, Mekonnen D, Abay Z.

Int J Clin Pharm. 2018 Oct;40(5):1209-1216. doi: 10.1007/s11096-018-0722-9. Epub 2018 Aug 28.

PMID:
30155773
21.

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy.

Dekkers BGJ, Veringa A, Marriott DJE, Boonstra JM, van der Elst KCM, Doukas FF, McLachlan AJ, Alffenaar JC.

Drugs Aging. 2018 Sep;35(9):781-789. doi: 10.1007/s40266-018-0576-9. Review.

22.

Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis.

Enke O, New HA, New CH, Mathieson S, McLachlan AJ, Latimer J, Maher CG, Lin CC.

CMAJ. 2018 Jul 3;190(26):E786-E793. doi: 10.1503/cmaj.171333.

23.

Patterns of platinum drug use in an acute care setting: a retrospective study.

Armstrong-Gordon E, Gnjidic D, McLachlan AJ, Hosseini B, Grant A, Beale PJ, Wheate NJ.

J Cancer Res Clin Oncol. 2018 Aug;144(8):1561-1568. doi: 10.1007/s00432-018-2669-6. Epub 2018 May 22.

PMID:
29789926
24.

Enhancing pharmacists' role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review.

Sakeena MHF, Bennett AA, McLachlan AJ.

Antimicrob Resist Infect Control. 2018 May 2;7:63. doi: 10.1186/s13756-018-0351-z. eCollection 2018. Review.

25.

Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study.

Counsell AB, Nguyen AD, Baysari MT, Kannangara DRW, McLachlan AJ, Day RO.

BMC Fam Pract. 2018 May 9;19(1):54. doi: 10.1186/s12875-018-0744-3.

26.

Investigating knowledge regarding antibiotics and antimicrobial resistance among pharmacy students in Sri Lankan universities.

Sakeena MHF, Bennett AA, Jamshed S, Mohamed F, Herath DR, Gawarammana I, McLachlan AJ.

BMC Infect Dis. 2018 May 8;18(1):209. doi: 10.1186/s12879-018-3107-8.

27.

A Scoping Review of Peer-led Education in Patient Safety Training.

Walpola RL, McLachlan AJ, Chen TF.

Am J Pharm Educ. 2018 Mar;82(2):6110. doi: 10.5688/ajpe6110. Review.

28.

Which supplements can I recommend to my osteoarthritis patients?

Liu X, Eyles J, McLachlan AJ, Mobasheri A.

Rheumatology (Oxford). 2018 May 1;57(suppl_4):iv75-iv87. doi: 10.1093/rheumatology/key005. Review.

PMID:
29506080
29.

Correction: Management of vertebral compression fracture in general practice: BEACH program.

Megale RZ, Pollack A, Britt H, Latimer J, Naganathan V, McLachlan AJ, Ferreira ML.

PLoS One. 2018 Feb 22;13(2):e0193531. doi: 10.1371/journal.pone.0193531. eCollection 2018.

30.

Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.

Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ.

J Pharm Pharmacol. 2019 Jan;71(1):129-138. doi: 10.1111/jphp.12858. Epub 2018 Feb 7. Review.

PMID:
29411879
31.

Barriers and facilitators to hospital pharmacists' engagement in medication safety activities: a qualitative study using the theoretical domains framework.

Mekonnen AB, McLachlan AJ, Brien JE, Mekonnen D, Abay Z.

J Pharm Policy Pract. 2018 Jan 23;11:2. doi: 10.1186/s40545-018-0129-y. eCollection 2018.

32.

Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review.

Redston MR, Hilmer SN, McLachlan AJ, Clough AJ, Gnjidic D.

J Alzheimers Dis. 2018;61(4):1639-1652. doi: 10.3233/JAD-170842.

PMID:
29278890
33.

Efficacy and Safety of Oral and Transdermal Opioid Analgesics for Musculoskeletal Pain in Older Adults: A Systematic Review of Randomized, Placebo-Controlled Trials.

Megale RZ, Deveza LA, Blyth FM, Naganathan V, Ferreira PH, McLachlan AJ, Ferreira ML.

J Pain. 2018 May;19(5):475.e1-475.e24. doi: 10.1016/j.jpain.2017.12.001. Epub 2017 Dec 11. Review.

PMID:
29241834
34.

What do Australian consumers, pharmacists and prescribers think about documenting indications on prescriptions and dispensed medicines labels?: A qualitative study.

Garada M, McLachlan AJ, Schiff GD, Lehnbom EC.

BMC Health Serv Res. 2017 Nov 15;17(1):734. doi: 10.1186/s12913-017-2704-3.

35.

Adverse Drug Events and Medication Errors in African Hospitals: A Systematic Review.

Mekonnen AB, Alhawassi TM, McLachlan AJ, Brien JE.

Drugs Real World Outcomes. 2018 Mar;5(1):1-24. doi: 10.1007/s40801-017-0125-6. Review.

36.

Exploring the enablers and barriers to implementing the Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) criteria in Australia: a qualitative study.

Page AT, Clifford RM, Potter K, Seubert L, McLachlan AJ, Hill X, King S, Clark V, Ryan C, Parekh N, Etherton-Beer CD.

BMJ Open. 2017 Aug 23;7(8):e017906. doi: 10.1136/bmjopen-2017-017906.

37.

Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions.

Adiwidjaja J, McLachlan AJ, Boddy AV.

Expert Opin Drug Metab Toxicol. 2017 Sep;13(9):953-972. doi: 10.1080/17425255.2017.1360279. Epub 2017 Aug 10. Review.

PMID:
28776444
38.

Abdominal functional electrical stimulation to improve respiratory function after spinal cord injury: a systematic review and meta-analysis.

McCaughey EJ, Borotkanics RJ, Gollee H, Folz RJ, McLachlan AJ.

Spinal Cord. 2017 Aug;55(8):798. doi: 10.1038/sc.2017.2.

PMID:
28775367
39.

Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure.

Brett J, Karanges EA, Daniels B, Buckley NA, Schneider C, Nassir A, Zoega H, McLachlan AJ, Pearson SA.

Aust N Z J Psychiatry. 2017 Oct;51(10):990-999. doi: 10.1177/0004867417721018. Epub 2017 Jul 31.

PMID:
28758432
40.

Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study.

Brett J, Daniels B, Karanges EA, Buckley NA, Schneider C, Nassir A, McLachlan AJ, Pearson SA.

Br J Clin Pharmacol. 2017 Nov;83(11):2581-2588. doi: 10.1111/bcp.13369. Epub 2017 Aug 16.

41.

Worsening trends in analgesics recommended for spinal pain in primary care.

Mathieson S, Valenti L, Maher CG, Britt H, Li Q, McLachlan AJ, Lin CC.

Eur Spine J. 2018 May;27(5):1136-1145. doi: 10.1007/s00586-017-5178-4. Epub 2017 Jun 21.

PMID:
28639074
42.

Comparison of effect sizes between enriched and nonenriched trials of analgesics for chronic musculoskeletal pain: a systematic review.

Yamato TP, Maher CG, Saragiotto BT, Shaheed CA, Moseley AM, Lin CC, Koes B, McLachlan AJ.

Br J Clin Pharmacol. 2017 Nov;83(11):2347-2355. doi: 10.1111/bcp.13350. Epub 2017 Aug 11. Review.

43.

Life-threatening drug interactions: what the physician needs to know.

Day RO, Snowden L, McLachlan AJ.

Intern Med J. 2017 May;47(5):501-512. doi: 10.1111/imj.13404. Review.

PMID:
28503886
44.

Management of vertebral compression fracture in general practice: BEACH program.

Megale RZ, Pollack A, Britt H, Latimer J, Naganathan V, McLachlan AJ, Ferreira ML.

PLoS One. 2017 May 4;12(5):e0176351. doi: 10.1371/journal.pone.0176351. eCollection 2017. Erratum in: PLoS One. 2018 Feb 22;13(2):e0193531.

45.

Pharmacist-led admission medication reconciliation before and after the implementation of an electronic medication management system.

Sardaneh AA, Burke R, Ritchie A, McLachlan AJ, Lehnbom EC.

Int J Med Inform. 2017 May;101:41-49. doi: 10.1016/j.ijmedinf.2017.02.001. Epub 2017 Feb 8.

PMID:
28347446
46.

Trial of Pregabalin for Acute and Chronic Sciatica.

Mathieson S, Maher CG, McLachlan AJ, Latimer J, Koes BW, Hancock MJ, Harris I, Day RO, Billot L, Pik J, Jan S, Lin CC.

N Engl J Med. 2017 Mar 23;376(12):1111-1120. doi: 10.1056/NEJMoa1614292.

47.

"I have nine specialists. They need to swap notes!" Australian patients' perspectives of medication-related problems following discharge from hospital.

Eassey D, McLachlan AJ, Brien JA, Krass I, Smith L.

Health Expect. 2017 Oct;20(5):1114-1120. doi: 10.1111/hex.12556. Epub 2017 Mar 17.

48.

Evaluating the Effectiveness of an Educational Intervention to Improve the Patient Safety Attitudes of Intern Pharmacists.

Walpola RL, Fois RA, McLachlan AJ, Chen TF.

Am J Pharm Educ. 2017 Feb 25;81(1):5. doi: 10.5688/ajpe8115.

49.

Authors' reply to the comment by Durg.

Abdel Shaheed C, McLachlan AJ, Maher CG.

Eur J Pain. 2017 Feb;21(2):400. doi: 10.1002/ejp.1005. No abstract available.

PMID:
28068005
50.

Medication reconciliation as a medication safety initiative in Ethiopia: a study protocol.

Mekonnen AB, McLachlan AJ, Brien JE, Mekonnen D, Abay Z.

BMJ Open. 2016 Nov 24;6(11):e012322. doi: 10.1136/bmjopen-2016-012322.

Supplemental Content

Loading ...
Support Center